A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study

Imlunestrant is an oral selective estrogen receptor degrader with favorable safety and preliminary efficacy in patients with advanced breast cancer. Pharmacodynamic (PD) biomarker data can optimize drug dosing; in this study, we present PD data from the EMBER-2 study.

A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study Read More »

Articles – Therapeutic Options & Guidelines for Early Stage Breast Cancer

Articles – Therapeutic Options & Guidelines for Early Breast Cancer Curated selection of peer-reviewed articles focusing on Breast Cancer advancements in the Asia-Pacific (APAC) region. This curated selection of research articles provides a broad overview of breast cancer treatments, including reviews of standard practices, emerging therapies, and clinical guidelines. The collection spans topics such as

Articles – Therapeutic Options & Guidelines for Early Stage Breast Cancer Read More »

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

Next Generation Sequencing (NGS) panels are increasingly used in advanced patients with cancer to guide therapy. There is, however, controversy about when should these panels be used, and about their impact on the clinical course.

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement Read More »

Faculty

Faculty – Breast Cancer Meet our Editorial Panel who are the key opinion leaders in the field of Breast Cancer. This expert panel in collaboration with the WILEY editorial team has curated the independent educational modules where you can get resources on the latest advancements in the diagnosis, treatment and management of Breast Cancer. Dr.

Faculty Read More »

This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.

Confirm